Pharmaceutical Discovery and Preclinical Development1

Dear all,

I hope this message finds you well.

As several of our members will be attending the AAPS NBC meeting in Boston (May 4–7, 2025) and the USP Convention in Washington, DC (May 5–8, 2025), we will be canceling our May 2025 monthly meeting.

In the meantime, I would like to share an update on our upcoming webinars, as outlined below.

• Theranostics Applications of Shell-Stabilized Nanobubbles, Speaker: Dr. Agata Exner, Case Western Reserve University, June 12, 2025
• From AI to Action: Integrating Science and Risk-Sharing in Drug Discovery, Speaker: Dr. Alison Jones, Charles River, September 16, 2025

Please feel free to let me know if you have any questions or suggestions.

Best regards.- Sudip

Hi Sudip and all,

The speaker I mentioned during our meeting for AI application in drug discovery:

Name: Bo Li. It seems that he is still a Ph.D. student at California Institute of Technology. He is CSO for an AI-Powered startup for drug discovery company.

His Bio could be found here: https://www.linkedin.com/in/boli99/

Email: [email protected]

If approved by PDPD community, he is available to give a webinar in the end of August (August 20-31)

Topic: TBD on AI application in drug discovery

!!! EXTERNAL EMAIL - Be careful when opening attachments or clicking links from unknown senders

Hi all,

Here is the introduction of the speaker. Is there any webinar available in the end of August?

Bo Li is the Cofounder and Chief Scientific Officer of QuanMol Tech, Inc., a startup pioneering AI-powered small-molecule discovery through its proprietary QuanMol ReDefine interaction-based drug design (IBDD) platform. A Caltech alumnus, Li has authored over 30 publications and granted patents in computational chemistry and molecular discovery. His work has been recognized by Nobel Laureate commentary, selection into global accelerators such as NVIDIA Inception and Endless Frontier Labs, and the Royal Society of Chemistry's Horizon Prize.

Thank you.